Aims The intermittent administration of chemotherapy is a means of preserving ... to verify whether the intermittent administration of docetaxel (DOC) improves the patients' QL.

Advanced triple-negative breast cancer is usually treated with chemotherapy – but response rates remain low. Researchers designed the trial to compare the effectiveness of docetaxel with carboplatin – ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

You may also hear of these being called chemotherapy medicines ... However, your doctor has now decided to treat you with docetaxel.

Get detailed information on Docetaxel, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

The US regulator has approved Nubeqa (darolutamide) in combination with docetaxel chemotherapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC), adding to its earlier ...